Related Experiment Video

Updated: Aug 9, 2026

Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease
02:34

Auricular Acupressure as an Adjuvant Treatment for Wheezing in Stable Chronic Obstructive Pulmonary Disease

Published on: May 10, 2024

Non-viral wheezing in preschool children: the effect of inhaled fluticasone on symptoms and lung function

I Chkhaidze1, M Kherkheulidze, N Kavlashvili

  • 1Tbilisi State Medical University.

Georgian Medical News
|April 1, 2006
PubMed

Insights

Inhaled corticosteroids significantly improved lung function and reduced symptoms in children with wheezing and Mycoplasma pneumoniae (MP) or Chlamydia pneumoniae (CP) infections, compared to antibiotics alone.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Respiratory Medicine

Background:

  • Wheezing in children is often associated with Mycoplasma pneumoniae (MP) and Chlamydia pneumoniae (CP) infections.
  • Identifying children at high risk for persistent asthma is crucial for early intervention.

Purpose of the Study:

  • To evaluate lung function changes in wheezing children with MP/CP infections based on treatment.
  • To assess the efficacy of inhaled corticosteroids (ICS) in children with significant wheezing at high risk for childhood asthma.

Main Methods:

  • A randomized controlled trial involving 54 children with wheezing and documented MP/CP infection.
  • Children were assigned to receive either inhaled fluticasone propionate plus macrolides or macrolides alone.
  • Lung function, daily symptom scores (DSS), and symptom-free days (SFD) were monitored over 16 weeks.

Main Results:

  • The group receiving ICS showed significant improvement in DSS and SFD compared to the control group.
  • Pulmonary function tests indicated significant improvement in the ICS group.
  • Treatment with ICS and macrolides was more effective than antibiotics alone in managing wheezing symptoms and improving lung function.

Conclusions:

  • Inhaled corticosteroids should be strongly considered for children experiencing wheezing with documented MP or CP infections.
  • Early intervention with ICS can mitigate persistent respiratory symptoms and improve lung function in at-risk children.
  • This study highlights the benefit of ICS in managing pediatric wheezing associated with specific microbial infections.

More Related Videos

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels05:31

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels

Published on: August 7, 2017

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms: